Dipl. Biochem. Dagmar SchneiderCurriculum VitaeDagmar Schneider studied Human Medicine at the Philipps-University of Marburg and University Hamburg and Biochemistry/Molecular Biology, with the subsidiary subjects Human Genetics, Pharmaceutical Chemistry and Microbiology, at the Christian-Albrechts-University of Kiel. She was educated in European Patent Law by Ascenion GmbH, and is certified in biostatistics, clinical epidemiology and clinical trials by the Harvard Medical School. After her studies about "WNT5A induced signaling events in human primary cells in the context of mycobacterial infection" and a cooperation with Amgen (USA) at the Microbial Interface Biology biosafety level 3 unit, Research Center Borstel, Leibnitz-Zentrum für Medizin und Biowissenschaften, she followed an invitation to the Fraunhofer Research Institution for Marine Biotechnology in Lübeck. At the Fraunhofer EMB she worked as the Head of the Cell Technology Laboratory and Assistant Team Leader. D.Schneider focused on cytotoxicity analysis, transfection and nanoparticle-labeling of human adult stem cells for time-lapse and Magnetic Particle Imaging. Her experience, innovative ideas and deep understanding of complex issues in different research areas led to her work as Scientific Business Manager at the Technology Transfer platform Tandem/Medisert, Center of Excellence for Technology and Engineering in Medicine and the BioMedTech Campus in Lübeck. In the context of the Wissenschaftsjahr 2012, D.Schneider was part of the management team that concepted the Lübeck Science Trail 2012. D. Schneider was involved in a number of teaching activities and was leading several research projects in cooperation with the Institute for Medical Engineering, Institute of Molecular Medicine, the Institute of Virology and Cell Biology at the University of Lübeck and the University Medical Center Schleswig-Holstein (UKSH). In 2013 D. Schneider founded nandatec GmbH, a Nanobiotechnology SME located in Lübeck and Innovation Center Itzehoe, where she functions as Managing Director until today. 2014 D. Schneider was the idea giver and co-founder of the BMWi- funded ZIM-network NanoFunDuS. 2015 nandatec received the KfW-award Gründerchampions Schleswig-Holstein 2015. She was nominated for the Publikumspreis KfW-Award and Start-up of the Year Award at the MICRONANO conference, Amsterdam in 2016. 2017 Schneider was one of three finalists of the IB.SH Unternehmerinnenpreis. During her career she was involved in fundraising for projects of over 28 Mio €. D. Schneider was a member of the selection committee Gründungsstipendium Kiel, Until today she is a member of the extended board of Life Science Nord e.V. and Supervisory Board Member of LSN Management GmbH. In order to strengthen the technology transfer D. Schneider has memberships in the Signal Transduction Society, the German Society for Stem Cell Research, and functions as Ambassador for nandatec at Biopeople Denmark.
Awards * Abstract Award: Deciphering WNT5A induced signaling events in human primary macrophages; Schneider D., 11th Joint Meeting of the Signal Transduction Society, Weimar, 2007. * KfW-Award GründerChampion Schleswig-Holstein, 2015. * Nominated for Publikumspreis KfW Award GründerChampions, 2015. * Nominated for Strat-up of the Year, MICRONANO Conference, Amsterdam, 2016. * Finalist 2017, IB.SH Unternehmerinnenpreis.
CertificatesHarvard Medical School certificates: Biostatistics and clinical trials certificates, Boston, MA,USA. Patents, utility models and employee invention act-how to protect your invention Ascenion GmbH, Borstel, DE. State-approved, MPG In-service Training Course in accordance with § 15 Para. 4 Sentence 1 GenTSV, Max Planck Institute of Biochemistry Martinsried, München, DE. Quality assurance: Werkzeuge und Methoden der Qualitätssicherung, Prüfplanung, Prozesskontrolle und Problemlösung, TÜV Nord, DE. Pathology and Biomedicine in Borstel, HOPE-fixation & Digital and Quantitative Molecular Pathology at the Research Center Borstel, Leibnitz-Zentrum für Medizin und Biowissenschaften, Borstel FZB, DE. Inclusive Leadership Training: Becoming a Successful Leader CatalystX-ILX. Negotiation Skills Workshop, Danfoss Center of Global Business, DCGB, Sonderborg, DK Expert in Nanotechnology Exploitation: Fundamentals in Nanotechnology and Applications, MESA+, enex, University of Twente, Enschede, NL.
PublicationsSchneider D., Harnessing data mining for
predictive modeling in ocular melanoma cancer care; Sensor 100 Cancer Diagnostic Technology Summit; book of abstracts;
p.6, 05.12.2023. Schneider D., Lange T., Jamrozik M.: 3 D-printed artificial eye with artificial intelligence for allergy testing; Berlin-Brandenburger Optik Tag, GERMAN CAPITAL REGION, excellence in photonics, WFBB, online conference; 31.08.2020. Schneider D., Seidenstecher M., Lüdtke-Buzug K.: The impact of smart surface modifications on cleaner oceans: NANDATEC® CLEANS1; NIBS, book of abstracts, p. 29, 2017. Book contribution: Schneider D., Lüdtke-Buzug K.: Biomaterials for Regenerative Medicine: Cytotoxicity of superparamagnetic iron oxide nanoparticles in stem cells; SPPHY 140; p.117-122, 2012. Lüdtke-Buzug K., Rapoport D.H., Schneider D.: Iron-oxide-loaded adult stem cells for Magnetic Particle Imaging in targeted Cancer therapy; AIP Conference Proceedings;
Scientific and Clinical Applications of Magnetic Carriers; 2010. Schaale K., Neumann J., Schneider D., Ehlers S., Reiling N.: Wnt signaling in macrophages: Augmenting and inhibiting mycobacteria-induced inflammatory responses; EU. J. Cell Biol.; 2010. Langner, S., Schneider D., Rapoport D.H., Reppel M., Hescheler J., Nguemo F., Kruse C.: Cryopreserved heart slices: An innovative approach for cardiovascular test systems; Fraunhofer Publica, Regenerative Medicine 4; 2009; No.6s, PP097, pp.215, World Conference on Regenerative Medicine; Leipzig; October 29.-31.; 2009. Schneider D.*, Reiling N.*, Ehlers S.: Mycobacterium tuberculosis-induced cell death of primary human monocytes an macrophages is not significantly modulated by TNF-targeted biologicals; J. Invest. Dermatol. Symp. Proc.; 2007. ebook contribution: Diplomarbeit Dagmar Schneider: Modulation von Apoptose und Lyse in mit Mykobakterien infizierten humanen Monozyten und Makrophagen mittels TNF-α Antagonisten; GRIN Verlag; 2006.Invited TalksSchneider D., Harnessing
data mining for predictive modeling in ocular melanoma cancer care; Sensor 100 Cancer Diagnostic Technology Summit; book
of abstracts; p.6, 05.12.2023. Schneider D.: 3 D-printed artificial eye with artificial intelligence for allergy testing; Berlin-Brandenburger Optik Tag, online conference; 31.08.2020. Schneider D.: The impact of smart surface modifications on cleaner oceans, International Conference Nanotechnology and Innovation in the Baltic Sea Region, NIBS, Kaunas, Lithuania, June 14.-16., 2017. Seidenstecher M., Schneider D.: Establishing a marine test system for anti-fouling compounds, Functional surfaces for clean oceans-new anti-fouling solutions, Maritimes Cluster, Green Shipping, NINa, WTSH, Otterndorf, 2016, Schneider D., Lüdtke-Buzug K.: Biomaterials for Regenerative Medicine: Cytotoxicity of superparamagnetic iron oxide nanoparticles in stem cells; 2nd International Workshop on Magnetic Particle Imaging, Lübeck, 2012. Schneider D., Heine H., Ehlers S., Reiling N.: Transfection of human primary macrophages to identify WNT5A- mediated geneactivation; 12th Symposium "Infektion und Immunabwehr" Burg Rothenfels, March 7.-9., 2008. Schneider D., Ehlers S., Reiling N.: Mycobacterium tuberculosis-induced cell death ofprimary human monocytes and macrophages is not significantly modulated by TNF-targeted biologicals; 11th Symposium "Infektion und Immunabwehr" Burg Rothenfels, March 9.-11., 2007. Schneider D., Ehlers S., Reiling N.: Mycobacterium tuberculosis-induced death of human monocytes is not influenced by TNF-targeted biologicals; 10th Joint Meeting, Signal Transduction Society, Receptors, Mediators and Genes, Weimar; November 10.-12., 2005. Poster Presentations (a selection)Schneider D., Lüdtke-Buzug K.: Biomaterials for Regenerative Medicine: Cytotoxicity of superparamagnetic iron oxide nanoparticles in stem cells, 2nd International Workshop on Magnetic Particle Imaging, Lübeck, 2012. Schneider D., Rapoport D. H., Lüdtke-Buzug K.: Bioengineering superparamagnetic iron oxide nanoparticles for stem cell- based immunotherapy; Tagung der Norddeutschen Immunologen; Forschungszentrum Borstel; November 2010. Lüdtke-Buzug K., Rapoport D.H., Schneider D.: Iron-oxide-loaded adult stem cells for Magnetic Particle Imaging in targeted Cancer therapy; AIP Conference Proceedings; Scientific and Clinical Applications of Magnetic Carriers; 2010. Schneider D., Rapoport D.H., Lüdtke-Buzug K.: Monitoring adult stem cell response on superparamagnetic iron oxide nanoparticles for cancer therapy; JSRM Special issue on 5th Annual Meeting of the German Stem Cell Society; 2010. Langner, S., Schneider D., Rapoport D.H., Reppel M., Hescheler J., Nguemo F., Kruse C.: Cryopreserved heart slices: An innovative approach for cardiovasculartest systems; Fraunhofer Publica, Regenerative Medicine 4; 2009; No.6s, PP097, pp.215, World Conference on Regenerative Medicine; Leipzig; October 29.-31., 2009. Schaale K, Schneider D., Ehlers S., Reiling N.: Exogenous Wnt5a promotes the inflammatory response of macrophages upon mycobacterial infection; Keystone Symposium, USA, January 5.-10., 2009. Schaale K, Schneider D., Reiling N.: Wnt5a induzierte Signaltransduktion in murinen Makrophagen im Kontext inflammatorischer Prozesse; Tag der Doktoranden; University of Lübeck; Juni 2008. Reiling N., Schneider D., Neumann J., Ehlers S., Lauber J., Buer J., Lange C., Goldmann T., Heine H.,Brandt E., Blumenthal A.: WNT5A and FZD5 link innate and adaptive immunity to infections; International Conference "WNT-Signaling in Development and Disease" MDC Berlin- Buch; September 12.-15., 2007. Schneider D., Ehlers S., Reiling N.: Mycobacterium tuberculosis-induced cell death ofprimary human monocytes and macrophages is not significantly modulated by TNF-targeted biologicals; 11th Symposium "Infektion und Immunabwehr" Burg Rothenfels, March 9.-11., 2007. Schneider D., Ehlers S., Reiling N.: Mycobacterium tuberculosis-induced death of human monocytes is not influenced by TNF-targeted biologicals; 10th Joint Meeting, Signal Transduction Society, Receptors, Mediators and Genes, Weimar; November 10.-12., 2005. Other activitiesConception
and coding of websites: Medisert, Tandem, Biomedtec, IWMPI, AGMT e.V., Karrieretag, Studierendentagung Dr. pharm. Meike RömerCurriculum VitaeDr. Römer studied Chemistry (2000-2001) and Pharmacy at the
Christian- Albrechts- University in Kiel, Germany. She graduated in 2005 and worked as PhD student at the Division of Pharmaceutical Technology, Faculty of Pharmacy, University of Helsinki in
Finland. 2008 she received her Doctor of Pharmacy-Thesis "Investigation on Physical Properties of Solid Dosage Forms during Pharmaceutical Processing: Process Analytical Applications of Vibrational
Spectroscopy"- from University of Helsinki. She was educated in Analytical Raman Spectroscopy and Chemometrics without equations, workshop FACSS, took part in the Unscrambler course, Multivariate
Data Analysis and the Transcript Doctor of Science courses of the Pharmacy University of Helsinki, in Finland.
As an assistant professor she worked at the University of Münster, Germany, teaching lab courses and giving lectures on MSc level Seminars on PAT and QbD, Supervision of Master students and PhD students, Supervision of landscape ecologist Master students. Dr. Römer functions as Pharmaceutical Expert and Senior Scientist for n a n d a t e c . AwardsHo L, Müller R, Römer M, Gordon KC, Heinämäki J, Kleinebudde P,
Pepper M, Rades T, Shen YC, Strachan CJ, Taday PF, Zeitler JA. Terahertz pulsed imaging as an analytical tool for tablet film coating. Proceedings of the first pan-European Science Conference on
Process Analytical Technology (EUPAT1), Gothenburg, Sweden, November 2006 (Poster Award).
PublicationsRömer M., Heinämäki J., Strachan C., Sandler N., Yliruusi J.; Prediction of film coating thickness of tablets by using a novel small scale coating plate system; AAPS PharmSciTech; 9(4): 1047–1053; Dec. 2008. Römer M, Heinämäki J, Miroshnyk I, Kivikero N, Sandler N, Rantanen J, Yliruusi J.; Phase transformation of erythromycin A dihydrate during fluid bed drying; J Pharm Sci.; 97(9):4020-9; Sep. 2008. Römer M., PhD
thesis Investigating physical properties of solid dosage forms during pharmaceutical processing: Process analytical applications of vibrational spectroscopy, University of Helsinki, Faculty of
Pharmacy, Division of Pharmaceutical Technology; August, 4th, 2008. Römer M., Heinämäki J., Miroshnyk I., Sandler N., Rantanen J., Yliruusi J.; Phase transformations of erythromycin A dihydrate during pelletisation and drying; Eur. J Pharm Biopharm; 67(1):246-52; 2007. Ho L., Müller R., Römer M., Gordon KC., Heinämäki J., Kleinebudde P., Pepper M. Rades T., Shen YC., Strachan CJ., Taday PF., Zeitler JA.; Analysis of Sustained-Release Tablet Film Coats using Terahertz Pulsed Imaging; Journal of Controlled Release; 119(3):253-6; 2007. Sandler, N., Ratanen J., Heinämäki J., Römer M., Marvola M., Yliruusi J.; Pellet Manufacturing by Extrusion-Spheronization Using Process Analytical Technology. AAPS PharmSCITech., 6(2): E174-E183; 2005. TalksRömer M,
Heinämäki J, Miroshnyk I, Sandler N, Rantanen J, Yliruusi J. Process Induced Transformations of Erythromycin Dihydrate During Drying, Proceedings of the 33rd International Meeting of the Federation
of Analytical Chemistry and Spectroscopy Societies (FACSS-SciX), Session: NIR Used as Process Analytical Tool, Orlando, Florida, USA, September 2006. Poster presentations (a selection)Ho L, Müller
R, Römer M, Gordon KC, Heinämäki J, Kleinebudde P, Pepper M, Rades T, Shen YC, Strachan CJ, Taday PF, Zeitler JA. Terahertz pulsed imaging as an analytical tool for tablet film coating. Proceedings
of the first pan-European Science Conference on Process Analytical Technology (EUPAT1), Gothenburg, Sweden, November 2006 (Poster Award). Other activitiesMaster thesis Supervisor and reviewer for Jan Lehman (MSc. Lök)
“Development of a classification model based on spectral properties of tannin to identify invasive Acacia longifolia species in dune ecosystems of South Portugal” October 2011 - June 2012.
Course instructor Multivariate data analysis - Theory and practical training (3 days); Developer and instructor - Software course at the Institute for Landscape ecology, University of Münster, Germany Workshop about semi solid formulations, Developer and instructor - Apothekerkammer. Practical training Pharmacy studies on Master level: semi solid formulations – Testing plausibility, incompatibility, emulsions, suspensions, rheology. Compulsory practical training e.g. matrix tablets, lyotropic liquid crystalline systems etc. Lectures Pharmacy studies on Master level: semi solid formulations, stability of formulations, novel analytical methods for quality assurance, Process analytics Pharmacy studies on Bachelor level – all relevant topics Seminar: Quality insurance – quality by design, design of experiments and process analytics Dr. med. Tobias LangeCurriculum VitaeDr. Lange studied Human Medicine at the University Hamburg 1994-2001. He was educated in Alternative Medicine at the Deutsche Paracelsius Schule für Naturheilverfahren. After his graduation in Human Medicine at the University Hamburg in 2004, he worked as a research associate at the Institute for Medical Biochemistry and Molecular Biology, Department Molecular Cell Biology of the University Hospital Eppendorf (UKE), Prof. Dr. Dr. U. Beisiegel in Hamburg. His research focus is in the field of adeno-viral vectors for cholesterol-regulated LDL-receptor expression. In December 2007 he received his Dr. med. (MD) about „Charakterisierung eines adenoviralen Vektors mit cholesterinregulierter LDL-Rezeptor Expression“ from the University Hamburg with "magna cum laude". Dr. Lange worked as assistant physician at the Hospital for Internal Medicine and the Cardiology of the University Medical Center Schleswig-Holsteins, Campus Kiel. September 2009 he became specialist in Internal Medicine and in 2017 cardiologist. At the time he works as Assistant Medical Director at the Intensive Care Department, Sana Klinikum Elmshorn and as an Independent Medical Reviewer and as GMP-, AMG-, MPG-certified clinical study investigator for n a n d a t e c.AwardsLudolph-Brauer-Posterpreis:
Epithelialisierung, Wachstumsfaktoren und antimikrobielle Peptide schützen vor Keiminvasion aus chronischen Analfisteln; Lange T.C.; Gremium der 34. Jahrestagung der
Nordwestdeutschen Gesellschaft für Innere Medizin; February 2008. PublicationsSchneider D., Lange T., Jamrozik M.: Microfluidic artificial eye with AI for COVID-19 testing;
NIBS-Nanotech for Life Science; Technical Digest; p.19, 05.08.2021.
Schneider D., Lange T., Jamrozik M.: 3 D-printed artificial eye with artificial intelligence for allergy testing; Berlin-Brandenburger Optik Tag, GERMAN CAPITAL REGION, excellence in photonics, WFBB, online conference; 31.08.2020. Kiehne K., Fincke A., Brunke G., Lange T., Fölsch U. R., Herzig K.
H.; Antimicrobial peptides in chronic anal fistula epithelium; Scandinavian Journal of Gastroenterology; 42: 1063-1069; 2007.
Lange T. C.; Dissertation: Charakterisierung eines adenoviralen Vektors mit cholesterinregulierter LDL-Rezeptor Expression; http://www.sub.uni-hamburg.de/opus/volltexte/2007/3488/; 2007. Kiehne K., Lange T., Finke A., Brunke G., U.R. Fölsch, Herzig K.; Antimicrobial peptide expression by the epithelia of chronic anal fistulas prevents systemic infection; Endorsed by the European Crohn`s and Colitis Organisation; Colorectal Diseases; Springer Verlag Volume 20, (6), 564, 2005. Poster PresentationsLange T., Brunke G., Meyer D., Herzig K.H., Kiehne K.;
Defensinregulation und Zytokinexpression bei Soorösophagitis; 110. Jahrestagung Deutsche Gesellschaft Innere Medizin, Wiesbaden; 2004.
Kiehne K., Lange T., Finke A., Brunke G., U.R. Fölsch U.R., Herzig K.H.; Antimicrobial peptide expression by the epithelia of chronic anal fistulas prevents systemic infection; Endorsed by the European Crohn`s and Colitis Organisation; Colorectal Diseases; Springer Verlag Volume 20, (6), 564, Stuttgart, 2005. Lange T., Fincke A., Brunke G., Kiehne K., Arlt. A., Fölsch U.R.; Epithelialisierung, Wachstumsfaktoren und antimikrobielle Peptide schützen vor Keiminvasion aus chronischen Analfisteln; 134. Jahrestagung der Nordwestdeutschen Gesellschaft für Innere Medizin; Hamburg 2008. Dr. rer. nat. Jan-Christian SodenkampCurriculum VitaeDr. Jan Sodenkamp studied Biology, Biochemistry, Bioinformatics and Zoology (2000-2006) at the University of Hamburg. He received his Diploma in Biology in 2006 and continued with his Ph.D. studies in infection immunology at the biosafety level 3 unit, Research Center Borstel / Leibnitz-Zentrum für Medizin und Biowissenschaften. In 2012 he was awarded his doctoral degree for the studies of the "gp130 dependent immune modulation during infection with Mycobacterium tuberculosis " by the University of Lübeck, Germany. He currently works as a London based Career Development Fellow at the National Institute for Medical Research were he continues his research of general mechanisms and induction of innate immunity during experimental malaria infection.Dr. Sodenkamp is teaching practical flow cytometry and troubleshooting courses for beginners on a regular basis. PublicationsBrugat T, Cunningham D,
Sodenkamp J, Coomes S, Wilson M, Spence PJ, et al.
Sequestration and histopathology in Plasmodium chabaudi malaria are influenced by the immune response in an organ-specific manner. Cell. Microbiol. 2013 Sep 5. Sodenkamp J, Waetzig H, Scheller J, Seegert D, Grötzinger J, Rose-John S, Ehlers S, Hölscher C Therapeutic targeting of interleukin-6 trans-signaling does not affect the outcome of experimental tuberculosis Immunobiology. 2012 Jan 20. Sodenkamp J, Behrends J, Förster I, Müller W, Ehlers S, Hölscher C gp130 on macrophages/granulocytes modulates inflammation during experimental tuberculosis. European Journal of Cell Biology. 2010 Nov. 2;:1–11. Rückerl D, Heßmann M, Sodenkamp J, Sonntag T, Hölscher A, Hölscher C Production of TH17-driving cytokines during experimental tuberculosis BD Bioscience - CBA Application Note. 2009 Greunke K, Braren I, Alpers I, Blank S, Sodenkamp J, Bredehorst R Recombinant IgY for improvement of immunoglobulin-based analytical applications. Clin. Biochem. 2008 Oct.; 41(14-15):1237–1244. Talks (T) and Poster Presentation (P)„9 Annual BioMalPar | EVIMalaR Conference" 2013, Heidelberg, Germany (P) Prof. Bodo Steiner Curriculum VitaeBodo Steiner studied Agricultural and Food Economics at the University of Kiel, Germany, University of Reading, UK and
Faculté de Droit & Science Economiques, Montpellier University, France. His primary professional interest centers around value chain management issues in the agri-food sector, with a strong
interest in the biotechnology and wine sector.Bodo Steiner is currently Professor MSO at the University of Southern Denmark and Adjunct Professor at the University of Alberta, Faculty of
Agricultural and Life Sciences, Canada. He has been president of a farming company in Germany, and has freelance management consulting experience from Canada, California and Germany, having
advised the Canadian Government and the European Commission. He has been research fellow and visiting scholar at the Department of Agricultural & Resource Economics, University of California at
Berkeley, as well as European Commission Research Training Fellow, at the Department of Agricultural Economics, University of Reading, UK.
|
+49 (0) 451-140 99 43
nandatec GmbH
Fraunhoferstr. 3
25524 Itzehoe
Germany